Researchers at the Technion – Israel Institute of Technology have discovered a way to potentially predict the success of immunotherapy treatment in cancer patients.
Immunotherapy involves encouraging the body’s immune system to attack the cancer cells. This can be complicated by the cancer cells “hiding” within the body or the immune system itself being reluctant to attack the cancer cells due to the threat to healthy surrounding cells.
And, while it has been proven to be a successful treatment against cancer, immunotherapy is only effective in around 40 percent of patients.
Comments are closed.